These observations, along with the known induction of apoD in affected brain regions in human AD and mouse models [20–26], underscore the importance of defining possible difference in apoD expression in different brain regions that may be susceptible to oxidative stress and neurodegenerative conditions. The gene discussed is APOD; the disease is Alzheimer disease.